Overview

  • Product name[Gln22]-Amyloid β Peptide (1-40)
  • Description
    Mutant amyloid β (1-40) peptide
  • Biological descriptionMutant amyloid β (1-40) peptide. Associated with Dutch type amyloidosis. Toxic to cultured endothelial cells (hBEC); aggregates on cell surface.
  • Purity> 95%

Properties

    References for [Gln22]-Amyloid β Peptide (1-40) (ab120820)

    This product has been referenced in:
    • Eisenhauer PB  et al. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant. J Neurosci Res 60:804-10 (2000). Read more (PubMed: 10861793) »
    • Walsh DM  et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272:22364-72 (1997). Read more (PubMed: 9268388) »
    • Jarrett JT  et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-7 (1993). Read more (PubMed: 8490014) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120820.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"